MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/hypertensionaha.112.200477

Медицинская библиотека · Hypertension (Dallas, Tex. : 1979) · 2012

A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.

Rahman Mahboob, Greene Tom, Phillips Robert A, Agodoa Lawrence Y, Bakris George L, Charleston Jeanne, Contreras Gabriel, Gabbai Francis, Hiremath Leena, Jamerson Kenneth, Kendrick Cynthia, Kusek John W, Lash James P, Lea Janice, Miller Edgar R, Rostand Stephen, Toto Robert, Wang Xulei, Wright Jackson T, Appel Lawrence J

СтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The objective of our study was to determine the effects of 2 antihypertensive drug dose schedules (PM dose and add-on dose) on nocturnal blood pressure (BP) in comparison with usual therapy (AM dose) in blacks with hypertensive chronic kidney disease and controlled office BP. In a 3-period, crossover trial, former participants of the African American Study of Kidney Disease were assigned to receive the following 3 regimens, each lasting 6 weeks, presented in random order: AM dose (once-daily antihypertensive medications taken in the morning), PM dose (once-daily antihypertensives taken at bedtime), and add-on dose (once-daily antihypertensives taken in the morning and an additional antihypertensive medication before bedtime [diltiazem 60-120 mg, hydralazine 25 mg, or additional ramipril 5 mg]). Ambulatory BP monitoring was performed at the end of each period. The primary outcome was nocturnal systolic BP. Mean age of the study population (n=147) was 65.4 years, 64% were men, and mean estimated glomerular filtration rate was 44.9 mL/min per 1.73 m(2). At the end of each period, mean (SE) nocturnal systolic BP was 125.6 (1.2) mm Hg in the AM dose, 123.9 (1.2) mm Hg in the PM dose, and 123.5 (1.2) mm Hg in the add-on dose. None of the pairwise differences in nocturnal, 24-hour, and daytime systolic BP was statistically significant. Among blacks with hypertensive chronic kidney disease, neither PM (bedtime) dosing of once-daily antihypertensive nor the addition of drugs taken at bedtime significantly reduced nocturnal BP compared with morning dosing of antihypertensive medications.

Для цитирования: Rahman Mahboob, Greene Tom, Phillips Robert A, Agodoa Lawrence Y, Bakris George L, Charleston Jeanne, Contreras Gabriel, Gabbai Francis, Hiremath Leena, Jamerson Kenneth, Kendrick Cynthia, Kusek John W, Lash James P, Lea Janice, Miller Edgar R, Rostand Stephen, Toto Robert, Wang Xulei, Wright Jackson T, Appel Lawrence J. A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.. Hypertension (Dallas, Tex. : 1979). 2012. DOI: 10.1161/hypertensionaha.112.200477.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.